Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Raythera is an innovative radiopharmaceutical company dedicated to developing next-generation targeted cancer therapies. We specialize in advanced radioisotope technology to create precision treatments for aggressive and resistant cancers. Our research focuses on targeted alpha and beta therapies that attack cancer cells while sparing healthy tissue. With a team of leading scientists and clinicians, we're pushing the boundarie...
Raythera is an innovative radiopharmaceutical company dedicated to developing next-generation targeted cancer therapies. We specialize in advanced radioisotope technology to create precision treatments for aggressive and resistant cancers. Our research focuses on targeted alpha and beta therapies that attack cancer cells while sparing healthy tissue. With a team of leading scientists and clinicians, we're pushing the boundaries of oncology to provide new hope for patients with limited treatment options.

List your booth number for exhibitions, ask us